First Episealer® surgery in the Asia-Pacific
Episurf Medical (Nasdaq: EPIS B) today announces that the first surgery with the knee implant Episealer® in the Asia-Pacific region has been scheduled. “This is a significant milestone for us, and we have identified significant opportunities in the Asia-Pacific region. Recently, we have increased our focus towards several new markets, in which the regulatory work is ongoing. Scheduling the first surgery outside of Europe is exciting. We are also happy for the fact that we are reaching commercial milestones, simultaneously as we are making significant progress within the clinical strategy”